Africa needs additional $3.6B to fight malaria, RBM partnership board says

NewsGuard 100/100 Score

"There is currently a $3.6 billion funding gap on malaria in Africa, according to the Roll Back Malaria Partnership, whose board concluded its 23rd meeting in Dakar, Senegal, on December 7," Devex's "Development Newswire" blog reports. Of the total, eight African countries -- Nigeria, Central African Republic, Cote d'Ivoire, Democratic Republic of the Congo, Ethiopia, Mauritania, Niger, and Sierra Leone -- need $2.4 billion to maintain their malaria prevention and treatment efforts over the next two years, "with Nigeria alone requiring nearly half that amount," according to the blog (Ravelo, 12/10).

"Board members emphasized the need for an intense and rapid mobilization of increased domestic resources as well as international donor funding, and innovative financing," according to an RBM Partnership press release. "We urgently need fresh ideas and new thinking about financing mechanisms that will reap greater resources for malaria. ... We are exploring all options -- financial transaction taxes, airline ticket taxes together with UNITAID, and a 'malaria bond,' among others," RBM Partnership Executive Director Nafo Traore said in the statement (12/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 3 trial of new malaria vaccine reveals promising results in protecting children